#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paget's disease of the vulva Autoimmune myositis Acute graft versus host disease Hepatitis D Myelodysplastic syndrome with excess blasts Dementia Alzheimer's type Pulmonary fibrosis Liver transplant rejection Primary mediastinal large B-cell lymphoma Biotinidase deficiency Stiff person syndrome Partial lipodystrophy Cervix carcinoma Hypocalcaemia Ovarian cancer stage IV More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Basic Information Rett syndrome – Basic Information Krabbe’s disease – Life with Disease Adrenogenital syndrome – Treatment Antithrombin III deficiency Hereditary optic atrophy Chordoma – Diagnostics Kearns-Sayre syndrome – Life with Disease Primary biliary cholangitis – Trials in Disease Wolfram syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midodrine Hydrochloride SODIUM SULFIDE NONAHYDRATE Cart 19/22 T Cells Glucose Vinblastine Sulfate GT-002 Cabazitaxel DISODIUM PHOSPHATE Nizaracianine Triflutate ZINC GLUCONATE Pilocarpine Hydrochloride VANDETANIB Memantine Hydrochloride Pritelivir Riboflavin Sodium Phosphate Setanaxib Isatuximab Gd2Il18Cart Amiloride LUXDEGALUTAMIDE More therapies…

    Learn about Your Condition

    Coeliac disease Infectious pleural effusion Epicondylitis Anal cancer stage II Dyskinesia Onychomycosis Cleft lip and palate Krabbe's disease Precocious puberty Andersen-Tawil syndrome Neck pain Behcet's syndrome Bladder cancer stage II Invasive breast carcinoma Colon cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • S095035
    • Tng462
    Denmark France Germany Italy Spain

  • Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sonelokimab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Bulgaria France Germany Italy Poland Spain

  • Study of rilvegostomig, trastuzumab deruxtecan, and AZD0901 in patients with locally advanced resectable gastroesophageal cancer before and after surgery

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Azd0901
    • Rilvegostomig
    • Trastuzumab Deruxtecan
    Italy Spain

  • Effectiveness and Safety of Rezafungin in Adults with Chronic Pulmonary Aspergillosis Who Have Limited Treatment Options

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchopulmonary aspergillosis
    Investigated Drugs:
    • Rezafungin Acetate
    Austria Belgium France Germany Hungary Italy +2

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Risankizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14

  • Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Multifocal motor neuropathy
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Empasiprubart
    Austria Belgium Czechia Denmark Estonia France +13

  • Study on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Bulevirtide
    • Elebsiran
    • Tobevibart
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

    Not recruiting

    2 1 1
    Investigated Drugs:
    • BRENSOCATIB
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +6
Previous Page
1 … 37 38 39 40 41 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!